ARBE ROBOTICS LTD (ARBE)

IL0011796625 - Common Stock

3.76  -0.24 (-6%)

Premarket: 3.54 -0.22 (-5.85%)

Fundamental Rating

2

Taking everything into account, ARBE scores 2 out of 10 in our fundamental rating. ARBE was compared to 126 industry peers in the Electronic Equipment, Instruments & Components industry. ARBE has a bad profitability rating. Also its financial health evaluation is rather negative. ARBE is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

In the past year ARBE has reported negative net income.
ARBE had a negative operating cash flow in the past year.
In the past 5 years ARBE always reported negative net income.
ARBE had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

ARBE has a Return On Assets of -106.75%. This is amonst the worse of the industry: ARBE underperforms 95.04% of its industry peers.
The Return On Equity of ARBE (-343.97%) is worse than 95.04% of its industry peers.
Industry RankSector Rank
ROA -106.75%
ROE -343.97%
ROIC N/A
ROA(3y)-69.31%
ROA(5y)-141.24%
ROE(3y)-86.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ARBE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

ARBE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ARBE has more shares outstanding
ARBE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -4.36, we must say that ARBE is in the distress zone and has some risk of bankruptcy.
ARBE's Altman-Z score of -4.36 is on the low side compared to the rest of the industry. ARBE is outperformed by 89.26% of its industry peers.
A Debt/Equity ratio of 1.79 is on the high side and indicates that ARBE has dependencies on debt financing.
The Debt to Equity ratio of ARBE (1.79) is worse than 92.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Altman-Z -4.36
ROIC/WACCN/A
WACC9.36%

2.3 Liquidity

ARBE has a Current Ratio of 1.44. This is a normal value and indicates that ARBE is financially healthy and should not expect problems in meeting its short term obligations.
ARBE has a worse Current ratio (1.44) than 79.34% of its industry peers.
ARBE has a Quick Ratio of 1.44. This is a normal value and indicates that ARBE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.44, ARBE is doing worse than 61.98% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.44

6

3. Growth

3.1 Past

ARBE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 23.38%, which is quite impressive.
Looking at the last year, ARBE shows a decrease in Revenue. The Revenue has decreased by -9.85% in the last year.
The Revenue has been growing by 64.54% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)23.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.78%
Revenue 1Y (TTM)-9.85%
Revenue growth 3Y64.54%
Revenue growth 5YN/A
Sales Q2Q%-74.95%

3.2 Future

ARBE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.73% yearly.
Based on estimates for the next years, ARBE will show a very strong growth in Revenue. The Revenue will grow by 140.40% on average per year.
EPS Next Y13.53%
EPS Next 2Y24.23%
EPS Next 3Y38.73%
EPS Next 5YN/A
Revenue Next Year-70.95%
Revenue Next 2Y19.96%
Revenue Next 3Y140.4%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

ARBE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ARBE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

ARBE's earnings are expected to grow with 38.73% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.23%
EPS Next 3Y38.73%

0

5. Dividend

5.1 Amount

ARBE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ARBE ROBOTICS LTD

NASDAQ:ARBE (1/7/2025, 8:00:01 PM)

Premarket: 3.54 -0.22 (-5.85%)

3.76

-0.24 (-6%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-27 2024-11-27/bmo
Earnings (Next)N/A N/A
Inst Owners39.73%
Inst Owner Change0%
Ins Owners10.22%
Ins Owner ChangeN/A
Market Cap319.86M
Analysts82.22
Price Target3.4 (-9.57%)
Short Float %0.98%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.05%
Min EPS beat(2)13.75%
Max EPS beat(2)20.34%
EPS beat(4)2
Avg EPS beat(4)3.34%
Min EPS beat(4)-11.25%
Max EPS beat(4)20.34%
EPS beat(8)2
Avg EPS beat(8)-11.15%
EPS beat(12)3
Avg EPS beat(12)-19.47%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-19.35%
Min Revenue beat(2)-73.86%
Max Revenue beat(2)35.16%
Revenue beat(4)1
Avg Revenue beat(4)-47.23%
Min Revenue beat(4)-91.43%
Max Revenue beat(4)35.16%
Revenue beat(8)1
Avg Revenue beat(8)-46.58%
Revenue beat(12)1
Avg Revenue beat(12)-41.5%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-9.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)6.71%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 277.42
P/FCF N/A
P/OCF N/A
P/B 18.58
P/tB 18.58
EV/EBITDA N/A
EPS(TTM)-0.59
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.01
BVpS0.2
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -106.75%
ROE -343.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-69.31%
ROA(5y)-141.24%
ROE(3y)-86.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 102.25%
Cap/Sales 51.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.44
Altman-Z -4.36
F-Score2
WACC9.36%
ROIC/WACCN/A
Cap/Depr(3y)155.26%
Cap/Depr(5y)126.24%
Cap/Sales(3y)25.91%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.78%
EPS Next Y13.53%
EPS Next 2Y24.23%
EPS Next 3Y38.73%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.85%
Revenue growth 3Y64.54%
Revenue growth 5YN/A
Sales Q2Q%-74.95%
Revenue Next Year-70.95%
Revenue Next 2Y19.96%
Revenue Next 3Y140.4%
Revenue Next 5YN/A
EBIT growth 1Y-26.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.93%
EBIT Next 3Y32.83%
EBIT Next 5YN/A
FCF growth 1Y18.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.96%
OCF growth 3YN/A
OCF growth 5YN/A